FDA Lifts Hold On CLLS' Trials, Double Delight For Roche, COLL Will Have To Wait

Today's Daily Dose brings you news about FDA approval of Roche's drugs; update on the clinical hold on Cellectis' UCART123 studies; CryoLife's progress in BioGlue clinical trial in China; harrowing wait for expanded approval of Keryx's kidney drug Auryxia and Lannett's outlook.

from RTT - Biotech http://ift.tt/2iAn5ZD
via IFTTT